Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

Multiple Sclerosis : Clinical and Laboratory Research
Margitta T KampmanLone Jørgensen

Abstract

High vitamin D levels may reduce the risk of relapses and disease progression in multiple sclerosis. This 96-week randomised controlled trial was designed to assess the effect of vitamin D(3) supplementation on bone mineral density in persons with multiple sclerosis. Supplementation with 20,000 IU vitamin D(3) weekly raised median serum 25-hydroxy vitamin D (25[OH]D) to 121 nmol/L. The modified intention to treat analysis included 35 persons in the vitamin D(3) group and 33 in the placebo group. Participants were age 21 to 50 years and fully ambulatory (median Expanded Disability Status Scale (EDSS) 2.5). We studied the effect of supplementing vitamin D(3) on the exploratory outcomes annualised relapse rate (ARR), EDSS, multiple sclerosis functional composite (MSFC) components, grip strength, and fatigue. After 96 weeks, there was no significant difference between groups in ARR (absolute difference 0.10, 95% CI -0.07 to 0.27; p = 0.25), EDSS (absolute difference -0.01, 95% CI -0.35 to 0.35; p = 0.97), MSFC components, grip strength, or fatigue. Supplementation with 20,000 IU vitamin D(3) weekly did not result in beneficial effects on the measured multiple sclerosis-related outcomes. This study was not powered to address clinica...Continue Reading

References

Apr 12, 2007·Journal of Neurology·I A F van der MeiA J McMichael
Jun 7, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·H TremlettUNKNOWN UBCMS Clinic Neurologists
Jun 19, 2008·Journal of Neurology·Charlotte YtterbergLena von Koch
Jul 26, 2008·Multiple Sclerosis : Clinical and Laboratory Research·J SmoldersR Hupperts
Oct 3, 2009·BMJ : British Medical Journal·H A Bischoff-FerrariJ Henschkowski
May 18, 2010·Journal of Photochemistry and Photobiology. B, Biology·Margitta T Kampman, Linn H Steffensen
May 19, 2010·European Journal of Endocrinology·Guri GrimnesRolf Jorde
May 25, 2010·Lancet Neurology·Alberto AscherioK Claire Simon
Jul 1, 2010·Acta Neurologica Scandinavica. Supplementum·S B GladK-M Myhr
Aug 3, 2010·Biochimica Et Biophysica Acta·Heather E C Hanwell, Brenda Banwell
Oct 1, 2010·Acta Neurologica Scandinavica·S KnippenbergJ Smolders
Oct 29, 2010·Medical Hypotheses·Anna Dorothea Hoeck, Martin L Pall
Nov 5, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Bianca Weinstock-GuttmanMurali Ramanathan
Nov 26, 2010·Current Opinion in Clinical Nutrition and Metabolic Care·Hataikarn Nimitphong, Michael F Holick
Mar 15, 2011·Journal of Neurology·Linn H SteffensenMargitta T Kampman
Mar 25, 2011·Journal of Neurology·Kelly Claire SimonA Ascherio
Apr 8, 2011·Neurology·O BeauchetG Allali
Apr 9, 2011·Journal of Neuroimmunology·Judith M Greer, Pamela A McCombe
May 6, 2011·Immunological Investigations·Ghasem MosayebiParviz Kokhaei
May 25, 2011·Neurology·J M GelfandA J Green
Jun 16, 2011·Current Medical Research and Opinion·Bernard M J UitdehaagDaniel D Mikol

❮ Previous
Next ❯

Citations

Aug 2, 2012·Journal of Neurology·Linn H SteffensenMargitta T Kampman
Jul 7, 2012·Acta neurologica Belgica·Alireza FaridarAmirreza Azimi
Oct 3, 2012·Nature Reviews. Neurology·Gloria von Geldern, Ellen M Mowry
Jul 12, 2012·Therapeutic Advances in Neurological Disorders·Charles Pierrot-DeseillignyJean-Claude Souberbielle
Jul 17, 2013·Nutrients·Barbara PrietlKarin Amrein
Apr 23, 2013·Journal of the Neurological Sciences·T F ScottC J Schramke
Apr 4, 2014·Journal of Neuroimmunology·Masaaki NiinoSeiji Kikuchi
Jan 23, 2016·Expert Review of Neurotherapeutics·Trygve Holmøy, Øivind Torkildsen
Dec 11, 2013·Expert Review of Neurotherapeutics·Jonatan SalzerPeter Sundström
Mar 14, 2013·Expert Opinion on Medical Diagnostics·Noel G Carlson, John W Rose
Oct 29, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Luisa AgnelloM Ciaccio
Dec 2, 2014·Pharmacology & Therapeutics·Katja SchmitzIrmgard Tegeder
Jan 22, 2013·Journal of Neuropathology and Experimental Neurology·Joost SmoldersInge Huitinga
Jan 4, 2013·Acta Neurologica Scandinavica. Supplementum·T HolmøyK I Løken-Amsrud
Dec 5, 2012·Acta Neurologica Scandinavica. Supplementum·Ø TorkildsenT Holmøy
May 28, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Agnes E NystadOivind Torkildsen
May 13, 2014·Critical Reviews in Clinical Laboratory Sciences·Edgard DelvinBernard Salle
Oct 1, 2013·Multiple Sclerosis and Related Disorders·Aravind GaneshScott Patten
Mar 24, 2015·Canadian Journal of Physiology and Pharmacology·Masaaki Niino, Yusei Miyazaki
Mar 7, 2015·La Presse médicale·Vasiliki PantazouRenaud Du Pasquier
Dec 3, 2014·Journal of the Neurological Sciences·S KimballS Venkateswaran
Feb 7, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Robert ZivadinovMurali Ramanathan
Dec 7, 2014·Journal of the Neurological Sciences·Prudence TetteyIngrid A F van der Mei
Jan 30, 2013·The EPMA Journal·Jan DörrFriedemann Paul
May 23, 2016·BMC Neurology·Soodeh Razeghi JahromiShekoofe Alaie
May 24, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Eleanor JamesSreeram V Ramagopalan
Mar 15, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Steve SimpsonIngrid van der Mei
Mar 14, 2013·Therapeutic Advances in Neurological Disorders·Charles Pierrot-Deseilligny, Jean-Claude Souberbielle
Jun 22, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Egil RøsjøTrygve Holmøy
May 18, 2016·Folia medica·Georgi Sv SlavovZahari I Zahariev
Dec 16, 2017·Neurology and Therapy·Martina B SintzelAnthony T Reder
Aug 9, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Brandon P MossCarrie M Hersh
Jun 1, 2018·International Journal of Molecular Sciences·Meenakshi UmarAouatef I Chouchane

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception
pregnancy test

Clinical Trials Mentioned

NCT00785473

Software Mentioned

PASAT
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.